<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:es="http://www.eibs.co.uk/easySite/xml/rss/1.0"
 xmlns:media="http://search.yahoo.com/mrss"
 xmlns:dc="http://purl.org/dc/elements/1.1"
><channel>
<title>RSS - Maximising return from science and technology</title>
<description>All Maximising return from science and technology articles</description>
<link>http://www.paconsulting.com/rss/technology-and-innovation/maximising-return-from-science-and-technology.rss</link>
<item>
<title>Catapult Communications  developing an LTE PHY</title>
<description>The program has gone from start to a customer-delivered operational PHY in less than 10 months. PA has provided Catapult with access to early versions of the system in order to allow the system integration to proceed in parallel. Joint integration has taken place, using common test vectors, and leading to a reliable, well understood platform. PA has helped transfer PHY level knowledge to Catapult to enable design evolution.</description>
<link>http://www.paconsulting.com/our-experience/catapult-communications-developing-an-lte-phy/</link>
<guid isPermaLink="false">809</guid>
<pubDate>Fri, 23 Mar 2012 16:36:10 GMT</pubDate>
<es:pubDateSort>20120323163610</es:pubDateSort>
<es:pageFirstCreationDate>Mon, 01 Jun 2009 09:24:27 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20090601092427</es:pageFirstCreationDateSort>
<es:pageLastModified>Fri, 23 Mar 2012 16:36:10 GMT</es:pageLastModified>
<es:pageLastModifiedSort>201203231643610</es:pageLastModifiedSort>
<dc:creator>Haider Shukhaer</dc:creator>
<category>Case study (Our experience)</category>
<category>Maximising return from science and technology</category>
<category>Technology &amp; Innovation</category>
<category>Technology and innovation services</category>
<category>Vendors</category>
<category>Driving innovative product development</category>
</item>
<item>
<title>Quintel Technology  developing a dual-tilt antenna system</title>
<description>As part of the overall product Quintel asked PA Consulting Group  to help with the design and development of the innovative RF Receiver PCB design. PA engineers worked from Quintel&#39;s original specification to design a PCB which could be prototyped, tested and deployed in field trials in less than six months.</description>
<link>http://www.paconsulting.com/our-experience/quintel-technology-developing-a-dual-tilt-antenna-system/</link>
<guid isPermaLink="false">946</guid>
<pubDate>Mon, 15 Oct 2012 13:18:25 GMT</pubDate>
<es:pubDateSort>20121015131825</es:pubDateSort>
<es:pageFirstCreationDate>Thu, 04 Jun 2009 13:08:46 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20090604130846</es:pageFirstCreationDateSort>
<es:pageLastModified>Mon, 15 Oct 2012 13:18:25 GMT</es:pageLastModified>
<es:pageLastModifiedSort>201210151311825</es:pageLastModifiedSort>
<dc:creator>Haider Shukhaer</dc:creator>
<category>Case study (Our experience)</category>
<category>New products and services</category>
<category>Maximising return from science and technology</category>
<category>Technology &amp; Innovation</category>
<category>Technology and innovation services</category>
<category>Vendors</category>
</item>
<item>
<title>Critikon  increasing competitiveness of patient-monitoring equipment for the health sector</title>
<description>Critikon wished to review the design of the DINAMAP Compact Monitor. PA Consulting Group was asked to redesign the product so that it was easier and less expensive to manufacture, without compromising performance or reliability.</description>
<link>http://www.paconsulting.com/our-experience/critikon-increasing-competitiveness-of-patient-monitoring-equipment/</link>
<guid isPermaLink="false">981</guid>
<pubDate>Mon, 08 Oct 2012 10:20:16 GMT</pubDate>
<es:pubDateSort>20121008102016</es:pubDateSort>
<es:pageFirstCreationDate>Fri, 05 Jun 2009 14:52:16 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20090605145216</es:pageFirstCreationDateSort>
<es:pageLastModified>Mon, 08 Oct 2012 10:20:16 GMT</es:pageLastModified>
<es:pageLastModifiedSort>2012100810102016</es:pageLastModifiedSort>
<dc:creator>Haider Shukhaer</dc:creator>
<category>Case study (Our experience)</category>
<category>Maximising return from science and technology</category>
<category>Medical devices</category>
</item>
<item>
<title>Cost reduction in medical devices throughout the life cycle</title>
<description>Healthcare companies urgently need to achieve cost reductions in all areas if they are to provide the levels of returns that investors expect. This is true even in the medical device market, where increased competition is intensifying the pressure to reduce costs.</description>
<link>http://www.paconsulting.com/our-thinking/cost-reduction-in-medical-devices/</link>
<guid isPermaLink="false">1115</guid>
<pubDate>Thu, 09 May 2013 10:37:35 GMT</pubDate>
<es:pubDateSort>20130509103735</es:pubDateSort>
<es:pageFirstCreationDate>Tue, 09 Jun 2009 16:13:29 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20090609161329</es:pageFirstCreationDateSort>
<es:pageLastModified>Wed, 10 Oct 2012 13:10:07 GMT</es:pageLastModified>
<es:pageLastModifiedSort>201210101311007</es:pageLastModifiedSort>
<dc:creator>Reg Hannam</dc:creator>
<category>Thought leadership (Our thinking)</category>
<category>Maximising return from science and technology</category>
<category>Drug delivery</category>
<category>Medical devices</category>
</item>
<item>
<title>Automatic injection devices</title>
<description>The market for automatic injection devices, or auto-injectors, is enjoying a period of rapid growth. In this article we discuss the user and business benefits that are driving this growth, the current state of the technology and the potential directions that the market may move in the future.</description>
<link>http://www.paconsulting.com/our-thinking/automatic-injection-devices/</link>
<guid isPermaLink="false">1163</guid>
<pubDate>Thu, 16 Aug 2012 11:26:12 GMT</pubDate>
<es:pubDateSort>20120816112612</es:pubDateSort>
<es:pageFirstCreationDate>Wed, 10 Jun 2009 11:11:29 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20090610111129</es:pageFirstCreationDateSort>
<es:pageLastModified>Thu, 16 Aug 2012 11:26:12 GMT</es:pageLastModified>
<es:pageLastModifiedSort>2012081611112612</es:pageLastModifiedSort>
<dc:creator>Reg Hannam</dc:creator>
<category>Thought leadership (Our thinking)</category>
<category>New products and services</category>
<category>Maximising return from science and technology</category>
<category>Drug delivery</category>
<category>Medical devices</category>
</item>
<item>
<title>US pharmaceutical company  developing a device  to inject a paste</title>
<description>PA is working with an international pharmaceutical company to develop a means for reliable and repeatable preparation and injection of a paste. We have developed prototypes to prove functionality and performance.</description>
<link>http://www.paconsulting.com/our-experience/us-pharmaceutical-company-developing-a-device-to-inject-a-paste/</link>
<guid isPermaLink="false">1468</guid>
<pubDate>Mon, 08 Oct 2012 11:38:21 GMT</pubDate>
<es:pubDateSort>20121008113821</es:pubDateSort>
<es:pageFirstCreationDate>Mon, 15 Jun 2009 11:14:19 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20090615111419</es:pageFirstCreationDateSort>
<es:pageLastModified>Mon, 08 Oct 2012 11:38:21 GMT</es:pageLastModified>
<es:pageLastModifiedSort>2012100811113821</es:pageLastModifiedSort>
<dc:creator>Haider Shukhaer</dc:creator>
<category>Case study (Our experience)</category>
<category>Maximising return from science and technology</category>
<category>Drug delivery</category>
<category>Medical devices</category>
</item>
<item>
<title>Elopak  setting new industry standards for aseptic cartons</title>
<description>PA, working with Elopak and its closure supplier, designed and developed a new type of sealer, the Pure-Cap U. The sophisticated Pure-Cap U has met all of Elopak&#39;s requirements by providing a hygienic, single-action, resealable opening device on aseptic cartons. Since its launch it has outperformed its nearest competitors and has been nominated for several awards.</description>
<link>http://www.paconsulting.com/our-experience/elopak-setting-new-industry-standards-for-aseptic-cartons/</link>
<guid isPermaLink="false">1735</guid>
<pubDate>Thu, 18 Oct 2012 15:35:18 GMT</pubDate>
<es:pubDateSort>20121018153518</es:pubDateSort>
<es:pageFirstCreationDate>Fri, 19 Jun 2009 16:11:04 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20090619161104</es:pageFirstCreationDateSort>
<es:pageLastModified>Thu, 18 Oct 2012 15:35:18 GMT</es:pageLastModified>
<es:pageLastModifiedSort>201210181533518</es:pageLastModifiedSort>
<dc:creator>Haider Shukhaer</dc:creator>
<category>Innovation</category>
<category>Case study (Our experience)</category>
<category>Maximising return from science and technology</category>
<category>Consumer products</category>
</item>
<item>
<title>Vorwerk - Developing a product for the kitchen of the 21st century</title>
<description>A food processor which can knead bread dough, weigh and mix the ingredients for a delicate sauce, cook the sauce and boil a litre of water rapidly sounds like something out of science fiction. But it is not: such a machine was developed by PA Consulting Group for Vorwerk, a leading German manufacturer of consumer appliances, and is now exceeding predicted sales for every country in which it has been launched.</description>
<link>http://www.paconsulting.com/our-experience/vorwerk-developing-a-product-for-the-kitchen-of-the-21st-century/</link>
<guid isPermaLink="false">1736</guid>
<pubDate>Fri, 25 May 2012 18:30:21 GMT</pubDate>
<es:pubDateSort>20120525183021</es:pubDateSort>
<es:pageFirstCreationDate>Fri, 19 Jun 2009 16:19:53 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20090619161953</es:pageFirstCreationDateSort>
<es:pageLastModified>Fri, 25 May 2012 18:30:21 GMT</es:pageLastModified>
<es:pageLastModifiedSort>201205251863021</es:pageLastModifiedSort>
<dc:creator>John O'Neill</dc:creator>
<category>Case study (Our experience)</category>
<category>New products and services</category>
<category>Maximising return from science and technology</category>
<category>Consumer products</category>
</item>
<item>
<title>Switch On  Technology in public services</title>
<description>PA Consulting Group&#39;s new publication for Government scientists and policy makers. SwitchOn is a collection of detailed articles on different aspects of science and technology  with this edition including pieces on new technologies, technologies crossing sectors, and technology innovation.</description>
<link>http://www.paconsulting.com/our-thinking/switch-on-technolgy-in-public-services/</link>
<guid isPermaLink="false">2453</guid>
<pubDate>Mon, 11 Jun 2012 10:56:39 GMT</pubDate>
<es:pubDateSort>20120611105639</es:pubDateSort>
<es:pageFirstCreationDate>Mon, 06 Jul 2009 08:55:43 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20090706085543</es:pageFirstCreationDateSort>
<es:pageLastModified>Mon, 11 Jun 2012 10:56:39 GMT</es:pageLastModified>
<es:pageLastModifiedSort>2012061110105639</es:pageLastModifiedSort>
<dc:creator>Adam Dorman</dc:creator>
<category>Thought leadership (Our thinking)</category>
<category>Maximising return from science and technology</category>
<category>Technology and innovation services</category>
</item>
<item>
<title>Cleantech consulting - supporting  all stages of the development cycle</title>
<description>PA Consulting Group&#39;s technology centre provides a full range of services to support Cleantech companies and investors throughout the technology development cycle. Cleantech embraces a diverse range of products, services, processes and technologies across all industry verticals. Cleantech has been a major recipient of technology investment in recent years. The focus is now on getting products to market and developing associated manufacturing processes.</description>
<link>http://www.paconsulting.com/our-experience/cleantech-companies-supporting-all-stages-of-the-development-cycle/</link>
<guid isPermaLink="false">2748</guid>
<pubDate>Thu, 18 Oct 2012 15:48:30 GMT</pubDate>
<es:pubDateSort>20121018154830</es:pubDateSort>
<es:pageFirstCreationDate>Tue, 14 Jul 2009 09:15:56 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20090714091556</es:pageFirstCreationDateSort>
<es:pageLastModified>Thu, 18 Oct 2012 15:48:30 GMT</es:pageLastModified>
<es:pageLastModifiedSort>201210181534830</es:pageLastModifiedSort>
<dc:creator>Haider Shukhaer</dc:creator>
<category>Innovation</category>
<category>Case study (Our experience)</category>
<category>Maximising return from science and technology</category>
<category>Technology and innovation services</category>
</item>
<item>
<title>Thermocore Medical - Designing an innovative thermography system to diagnose serious heart problems</title>
<description>PA Consulting Group has helped Thermocore Medical to develop a new diagnostic system that assesses patients for the likelihood of a sudden heart attack. At the heart of the system is a miniaturised, rapid exchange catheter, which is designed to detect and map small temperature variations inside the coronary arteries. These temperature variations are believed to be caused by vulnerable plaque  one of the major causes of sudden heart attack.</description>
<link>http://www.paconsulting.com/our-thinking/thermocore-medical-designing-an-innovative-thermography-system-to-diagnose-serious-heart-problems/</link>
<guid isPermaLink="false">4925</guid>
<pubDate>Thu, 18 Oct 2012 13:44:41 GMT</pubDate>
<es:pubDateSort>20121018134441</es:pubDateSort>
<es:pageFirstCreationDate>Tue, 06 Oct 2009 14:25:36 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20091006142536</es:pageFirstCreationDateSort>
<es:pageLastModified>Thu, 18 Oct 2012 13:44:41 GMT</es:pageLastModified>
<es:pageLastModifiedSort>201210181314441</es:pageLastModifiedSort>
<dc:creator>Haider Shukhaer</dc:creator>
<category>Case study (Our experience)</category>
<category>New products and services</category>
<category>Maximising return from science and technology</category>
<category>Medical devices</category>
<category>New products and services</category>
</item>
<item>
<title>Fuel cells  scaling up for success</title>
<description>Fuel cells are a low carbon technology on the brink of commercialisation worldwide.  Upcoming component and systems developments may provide a breakthrough in the cost of fuel cell systems.  
PA helps companies to bring products quickly to market.</description>
<link>http://www.paconsulting.com/our-thinking/fuel-cells-scaling-up-for-success/</link>
<guid isPermaLink="false">5214</guid>
<pubDate>Thu, 18 Apr 2013 17:08:26 GMT</pubDate>
<es:pubDateSort>20130418170826</es:pubDateSort>
<es:pageFirstCreationDate>Mon, 19 Oct 2009 15:18:56 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20091019151856</es:pageFirstCreationDateSort>
<es:pageLastModified>Thu, 18 Apr 2013 17:08:01 GMT</es:pageLastModified>
<es:pageLastModifiedSort>201304181750801</es:pageLastModifiedSort>
<dc:creator>Karsten Gross</dc:creator>
<category>Thought leadership (Our thinking)</category>
<category>Maximising return from science and technology</category>
<category>Technology and innovation services</category>
<category>Greening business</category>
<category>Realising green operations</category>
</item>
<item>
<title>Once bitten, twice shy?  Major pharmaceutical companies are ignoring truly nanoenabled drugs at their peril</title>
<description>Major pharmaceutical companies have launched a handful of drugs with nano-characteristics in recent years, but revenue has been slow to materialise.  However, truly nanoenabled drugs  designed from first principles and structurally engineered to deliver particular drugs to targeted sites  promise revolutionary treatments and impressive profits.</description>
<link>http://www.paconsulting.com/our-thinking/once-bitten-twice-shy-major-pharmaceutical-companies-are-ignoring-truly-nanoenabled-drugs-at-their-peril/</link>
<guid isPermaLink="false">6002</guid>
<pubDate>Thu, 18 Oct 2012 13:59:41 GMT</pubDate>
<es:pubDateSort>20121018135941</es:pubDateSort>
<es:pageFirstCreationDate>Wed, 18 Nov 2009 15:09:40 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20091118150940</es:pageFirstCreationDateSort>
<es:pageLastModified>Thu, 18 Oct 2012 13:59:41 GMT</es:pageLastModified>
<es:pageLastModifiedSort>201210181315941</es:pageLastModifiedSort>
<dc:creator>Haider Shukhaer</dc:creator>
<category>Thought leadership (Our thinking)</category>
<category>Maximising return from science and technology</category>
<category>Technology and innovation services</category>
<category>Drug delivery</category>
<category>Delivering value from R&amp;D</category>
</item>
<item>
<title>Open Innovation in Science and Technology  Do you have the right people for the job?</title>
<description>Transformation to an Open Innovation culture is a challenge for any company. Open Innovation encourages sharing and exploration of opportunities with external partners.  This means that our scientists and engineers, now need to adopt a broader set of skills.</description>
<link>http://www.paconsulting.com/our-thinking/open-innovation-in-science-and-technology-do-you-have-the-right-people-for-the-job/</link>
<guid isPermaLink="false">6407</guid>
<pubDate>Wed, 17 Oct 2012 15:34:18 GMT</pubDate>
<es:pubDateSort>20121017153418</es:pubDateSort>
<es:pageFirstCreationDate>Wed, 02 Dec 2009 14:52:32 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20091202145232</es:pageFirstCreationDateSort>
<es:pageLastModified>Wed, 17 Oct 2012 15:34:18 GMT</es:pageLastModified>
<es:pageLastModifiedSort>201210171533418</es:pageLastModifiedSort>
<dc:creator>Haider Shukhaer</dc:creator>
<category>Innovation</category>
<category>Thought leadership (Our thinking)</category>
<category>Maximising return from science and technology</category>
<category>Transforming innovation performance</category>
</item>
<item>
<title>European Biopharmaceutical Review - Nano-enabled drugs: once bitten, twice shy? December 2009</title>
<description>Nanotech-based reformulations of existing drugs have failed to inspire Big Pharma  but truly nano-enabled drugs offer real potential for innovation and companies ignore them at their  peril.</description>
<link>http://www.paconsulting.com/introducing-pas-media-site/highlighting-pas-expertise-in-the-media/opinion-pieces-by-pas-experts/european-biopharmaceutical-review-nano-enabled-drugs-once-bitten-twice-shy-december-2009/</link>
<guid isPermaLink="false">6875</guid>
<pubDate>Wed, 23 Dec 2009 00:00:00 GMT</pubDate>
<es:pubDateSort>20091223000000</es:pubDateSort>
<es:pageFirstCreationDate>Wed, 23 Dec 2009 15:46:43 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20091223154643</es:pageFirstCreationDateSort>
<es:pageLastModified>Tue, 11 May 2010 11:27:08 GMT</es:pageLastModified>
<es:pageLastModifiedSort>2010051111112708</es:pageLastModifiedSort>
<category>Healthcare</category>
<category>News and articles content (for right-hand side)</category>
<category>Media - PA in the media (list pages only)</category>
<category>Maximising return from science and technology</category>
<category>Opinion by PA</category>
<category>Technology &amp; Innovation</category>
<category>Technology and innovation services</category>
<category>Healthcare R&amp;D</category>
<category>Smart infrastructure</category>
</item>
<item>
<title>Successful PA Consulting and ERBI Cambridge seminar for emerging companies points the way to economic recovery</title>
<description>Successful PA Consulting and ERBI Cambridge seminar for emerging companies points the way to economic recovery</description>
<link>http://www.paconsulting.com/our-thinking/successful-pa-consulting-and-erbi-cambridge-seminar-for-emerging-companies-points-the-way-to-economic-recovery/</link>
<guid isPermaLink="false">7938</guid>
<pubDate>Tue, 07 Aug 2012 10:07:38 GMT</pubDate>
<es:pubDateSort>20120807100738</es:pubDateSort>
<es:pageFirstCreationDate>Tue, 16 Feb 2010 20:25:21 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20100216202521</es:pageFirstCreationDateSort>
<es:pageLastModified>Tue, 07 Aug 2012 10:07:38 GMT</es:pageLastModified>
<es:pageLastModifiedSort>2012080710100738</es:pageLastModifiedSort>
<dc:creator>Reg Hannam</dc:creator>
<category>Thought leadership (Our thinking)</category>
<category>Maximising return from science and technology</category>
<category>Technology and innovation services</category>
<category>Drug delivery</category>
<category>Delivering value from R&amp;D</category>
<category>The zombie economy: leading in times of uncertainty  </category>
</item>
<item>
<title>Delivering new healthcare technologies to market  helping emerging companies make it big</title>
<description>PA Consulting Group has a long track record of working with emerging UK healthcare technology based companies trying to take innovative and potentially disruptive new products to market.</description>
<link>http://www.paconsulting.com/our-thinking/delivering-new-healthcare-technologies-to-market-helping-emerging-companies-make-it-big/</link>
<guid isPermaLink="false">9613</guid>
<pubDate>Thu, 18 Oct 2012 13:37:54 GMT</pubDate>
<es:pubDateSort>20121018133754</es:pubDateSort>
<es:pageFirstCreationDate>Thu, 13 May 2010 15:39:34 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20100513153934</es:pageFirstCreationDateSort>
<es:pageLastModified>Thu, 18 Oct 2012 13:37:54 GMT</es:pageLastModified>
<es:pageLastModifiedSort>201210181313754</es:pageLastModifiedSort>
<dc:creator>Haider Shukhaer</dc:creator>
<category>Thought leadership (Our thinking)</category>
<category>Maximising return from science and technology</category>
<category>Technology and innovation services</category>
<category>Drug delivery</category>
<category>Delivering value from R&amp;D</category>
<category>The zombie economy: leading in times of uncertainty  </category>
</item>
<item>
<title>PA Open Innovation survey report</title>
<description>Open innovation (OI) helps companies access new technologies and innovation at a faster rate and lower cost than can be achieved internally. Yet many companies have not yet developed ways of maximising its potential.  


To help identify the key success factors for Open Innovation, PA Consulting Group has compiled a report drawing on the experience of leading companies. We talked to R&amp;D and marketing professionals in sectors ranging from pharmaceutical and medical device to large engineering and consumer</description>
<link>http://www.paconsulting.com/our-thinking/pa-open-innovation-survey-report/</link>
<guid isPermaLink="false">12037</guid>
<pubDate>Tue, 04 Sep 2012 12:10:18 GMT</pubDate>
<es:pubDateSort>20120904121018</es:pubDateSort>
<es:pageFirstCreationDate>Mon, 13 Sep 2010 15:50:20 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20100913155020</es:pageFirstCreationDateSort>
<es:pageLastModified>Tue, 04 Sep 2012 12:10:18 GMT</es:pageLastModified>
<es:pageLastModifiedSort>2012090412121018</es:pageLastModifiedSort>
<dc:creator>Reg Hannam</dc:creator>
<category>Innovation</category>
<category>Thought leadership (Our thinking)</category>
<category>Maximising return from science and technology</category>
<category>Transforming innovation performance</category>
</item>
<item>
<title>Creating a culture of collaboration to drive open innovation</title>
<description>Creating a culture of collaboration to drive open innovation.</description>
<link>http://www.paconsulting.com/our-thinking/creating-a-culture-of-collaboration-to-drive-open-innovation/</link>
<guid isPermaLink="false">13883</guid>
<pubDate>Tue, 16 Oct 2012 16:57:41 GMT</pubDate>
<es:pubDateSort>20121016165741</es:pubDateSort>
<es:pageFirstCreationDate>Sat, 13 Nov 2010 20:09:08 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20101113200908</es:pageFirstCreationDateSort>
<es:pageLastModified>Tue, 16 Oct 2012 16:57:41 GMT</es:pageLastModified>
<es:pageLastModifiedSort>201210161645741</es:pageLastModifiedSort>
<dc:creator>Haider Shukhaer</dc:creator>
<category>Innovation</category>
<category>Thought leadership (Our thinking)</category>
<category>Maximising return from science and technology</category>
<category>Transforming innovation performance</category>
</item>
<item>
<title>Charting a new course -  maximizing the commercial value of healthcare investments</title>
<description>Charting a new course -  maximizing the commercial value of healthcare investments</description>
<link>http://www.paconsulting.com/our-thinking/charting-a-new-course-maximizing-the-commercial-value-of-healthcare-investments/</link>
<guid isPermaLink="false">18180</guid>
<pubDate>Fri, 18 Nov 2011 13:40:07 GMT</pubDate>
<es:pubDateSort>20111118134007</es:pubDateSort>
<es:pageFirstCreationDate>Thu, 23 Jun 2011 20:53:47 GMT</es:pageFirstCreationDate>
<es:pageFirstCreationDateSort>20110623205347</es:pageFirstCreationDateSort>
<es:pageLastModified>Fri, 18 Nov 2011 13:40:06 GMT</es:pageLastModified>
<es:pageLastModifiedSort>201111181314006</es:pageLastModifiedSort>
<dc:creator>Haider Shukhaer</dc:creator>
<category>Thought leadership (Our thinking)</category>
<category>New products and services</category>
<category>Maximising return from science and technology</category>
<category>Drug delivery</category>
<category>Medical devices</category>
</item>
</channel>
</rss>
